Literature DB >> 20968131

Past, present and future of the cervical cancer screening in Latvia.

Ilze Viberga1, Ludmila Engele, Paolo Baili.   

Abstract

OBJECTIVE: The present descriptive study summarizes the historical activity on cervical cancer screening in Latvia, assesses the current screening situation, and defines the existing and expected obstacles and problems for the implementation of a proper organized population-based cervical cancer screening program in Latvia.
MATERIAL AND METHODS: Available data on cervical cancer burden were collected from Latvian cancer registry. Availability of trained medical staff and laboratory systems were obtained through the Latvian Association of Cytologists and the Health Compulsory Insurance State Agency of Latvia (HCISA).
RESULTS: Cervical cancer incidence in Latvia is increasing since 1989 when the compulsory preventive gynecologic examinations were stopped. Cervical opportunistic screening program in Latvia should be performed by GPs. But only 30 out of 1470 GPs provide gynecological care for their patients while, out of 484 certified gynecology practitioners, 35 had direct contractual relationship with the HCISA while 398 had only an indirect contractual relationship with the Agency. Moreover, in Latvia, there are about 29 laboratory specialists employed with cytological testing with an average age of 57 years: 13 of them have already passed the retirement limit.
CONCLUSIONS: Traditionally in Latvia, most women request gynecological services for preventive and health promotion reasons or in the case of having a gynecological disease. So the overloaded general practitioners and the lack of involvement of gynecologists are one of the main obstacles to solve for implementing an organized screening program in Latvia. Moreover insufficient availability of quality-assured services and resources for cytology testing and other services of the program, and for monitoring and evaluating the whole program, must be considered in the implementation of a comprehensive screening plan.t

Entities:  

Mesh:

Year:  2010        PMID: 20968131     DOI: 10.1177/030089161009600404

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  2 in total

1.  Cytology use for cervical cancer screening in Portugal: results from the 2005/2006 National Health Survey.

Authors:  Mariana Oliveira; Bárbara Peleteiro; Nuno Lunet
Journal:  Eur J Public Health       Date:  2013-06-20       Impact factor: 3.367

2.  Cervical Cancer in the Baltic States: Can Intelligent and Personalized Cancer Screening Change the Situation?

Authors:  Mindaugas Stankūnas; Kersti Pärna; Anna Tisler; Anda Ķīvīte-Urtāne; Una Kojalo; Jana Zodzika; Nicholas Baltzer; Jan Nygard; Mari Nygard; Anneli Uuskula
Journal:  Acta Med Litu       Date:  2022-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.